Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank83
3Y CAGR+75.3%
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+75.3%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
5.4x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2024$1.53M-1.5%
2023$1.56M+14.3%
2022$1.36M+378.2%
2021$285000.00-
2020$0.00-
2019$0.00-100.0%
2018$1.24M-